InVivo Therapeutics Holdings Financials
NVIVDelisted Stock | USD 1.38 0.07 5.34% |
InVivo |
Understanding current and past InVivo Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of InVivo Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in InVivo Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in InVivo Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of InVivo Therapeutics Holdings. Check InVivo Therapeutics' Beneish M Score to see the likelihood of InVivo Therapeutics' management manipulating its earnings.
InVivo Therapeutics Stock Summary
InVivo Therapeutics competes with Virax Biolabs, Revelation Biosciences, Kiora Pharmaceuticals, NextCure, and CytomX Therapeutics. InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US46186M6057 |
Business Address | One Kendall Square, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.invivotherapeutics.com |
Phone | 617 863 5500 |
Currency | USD - US Dollar |
InVivo Therapeutics Key Financial Ratios
Return On Equity | -0.98 | |||
Return On Asset | -0.54 | |||
Target Price | 37.5 | |||
Beta | 0.66 | |||
Z Score | -18.62 |
InVivo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining InVivo Therapeutics's current stock value. Our valuation model uses many indicators to compare InVivo Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InVivo Therapeutics competition to find correlations between indicators driving InVivo Therapeutics's intrinsic value. More Info.InVivo Therapeutics Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value InVivo Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.InVivo Therapeutics Market Pulse
Quote | 1.38 |
Change(%) | 5.34 |
Change | 0.07 |
Open | 1.31 |
Low | 1.31 |
High | 1.4 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as InVivo Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of InVivo has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if InVivo Therapeutics' financials are consistent with your investment objective using the following steps:- Review InVivo Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand InVivo Therapeutics' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare InVivo Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if InVivo Therapeutics' stock is overvalued or undervalued.
InVivo Therapeutics November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of InVivo Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InVivo Therapeutics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of InVivo Therapeutics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing InVivo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InVivo Therapeutics's daily price indicators and compare them against related drivers.
Downside Deviation | 4.42 | |||
Information Ratio | (0.01) | |||
Maximum Drawdown | 18.31 | |||
Value At Risk | (6.87) | |||
Potential Upside | 8.0 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world |